Clinical trial · Observational
Towards an Understanding of Barriers and Delays in the Diagnosis of Anal Cancer
NCT07455942CI-TRIAL-00125000FRACASrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study examines care pathways in 300 patients with anal squamous cell carcinoma to identify barriers and delays in diagnosis, assess the impact of screening and access to care, and improve awareness, screening practices, and early diagnosis.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| HPV-induced Cancer | — | UNRESOLVED | — |
| Squamous Cell Carcinoma of the Anal Canal | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| self-administered questionnaire | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Patients diagnosed with squamous cell carcinoma of the anal canal
- description
- Adult patients diagnosed with histologically confirmed anal squamous cell carcinoma.
- interventionNames
- Other: self-administered questionnaire
Primary outcomes (1)
- measure
- First symptom(s) and the histological diagnosis
- timeFrame
- At the inclusion
- description
- Time between the first symptom(s) and the histological diagnosis of anal squamous cell carcinoma.
Secondary outcomes (4)
- measure
- Primary tumor, regional nodes, metastasis (TNM) ) stage comparison
- timeFrame
- At the inclusion
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Male or female ≥ 18 years 2. Histologically proven invasive or microinvasive squamous cell carcinoma of the anus 3. Having read and understood the information letter provided, either: i. After disclosure of the diagnosis, or ii. At the latest 6 months after initiation of treatment (surgical excision, radiotherapy, or chemoradiotherapy) 4. Affiliated with a social security system Exclusion Criteria: 1. Refusal to participate in the protocol 2. Other histological types: lymphoma, adenocarcinoma, neuroendocrine tumor, etc. 3. Time since treatment initiation greater than 6 months 4. Protected persons (pregnant women, breastfeeding women, individuals under guardianship or curators, minors, persons deprived of liberty, or persons unable to express informed consent).
References
Publications (0)
Data not yet available
No reference posted for this study.